These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23099851)

  • 1. miR-125b promotes cell death by targeting spindle assembly checkpoint gene MAD1 and modulating mitotic progression.
    Bhattacharjya S; Nath S; Ghose J; Maiti GP; Biswas N; Bandyopadhyay S; Panda CK; Bhattacharyya NP; Roychoudhury S
    Cell Death Differ; 2013 Mar; 20(3):430-42. PubMed ID: 23099851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of the Ndc80 complex protein, HEC1, by Nek2 kinase modulates chromosome alignment and signaling of the spindle assembly checkpoint.
    Wei R; Ngo B; Wu G; Lee WH
    Mol Biol Cell; 2011 Oct; 22(19):3584-94. PubMed ID: 21832156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive Mad1 targeting to kinetochores uncouples checkpoint signalling from chromosome biorientation.
    Maldonado M; Kapoor TM
    Nat Cell Biol; 2011 Apr; 13(4):475-82. PubMed ID: 21394085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear pores protect genome integrity by assembling a premitotic and Mad1-dependent anaphase inhibitor.
    Rodriguez-Bravo V; Maciejowski J; Corona J; Buch HK; Collin P; Kanemaki MT; Shah JV; Jallepalli PV
    Cell; 2014 Feb; 156(5):1017-31. PubMed ID: 24581499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATM-mediated Mad1 Serine 214 phosphorylation regulates Mad1 dimerization and the spindle assembly checkpoint.
    Yang C; Hao J; Kong D; Cui X; Zhang W; Wang H; Guo X; Ma S; Liu X; Pu P; Xu B
    Carcinogenesis; 2014 Sep; 35(9):2007-13. PubMed ID: 24728176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RED, a spindle pole-associated protein, is required for kinetochore localization of MAD1, mitotic progression, and activation of the spindle assembly checkpoint.
    Yeh PC; Yeh CC; Chen YC; Juang YL
    J Biol Chem; 2012 Apr; 287(15):11704-16. PubMed ID: 22351768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mitotic role for Mad1 beyond the spindle checkpoint.
    Emre D; Terracol R; Poncet A; Rahmani Z; Karess RE
    J Cell Sci; 2011 May; 124(Pt 10):1664-71. PubMed ID: 21511728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the in vivo function of Mad1:C-Mad2 in the spindle assembly checkpoint.
    Fava LL; Kaulich M; Nigg EA; Santamaria A
    EMBO J; 2011 Jul; 30(16):3322-36. PubMed ID: 21772247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LMO7 exerts an effect on mitosis progression and the spindle assembly checkpoint.
    Tzeng YW; Li DY; Chen Y; Yang CH; Chang CY; Juang YL
    Int J Biochem Cell Biol; 2018 Jan; 94():22-30. PubMed ID: 29158164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation regulates the p31Comet-mitotic arrest-deficient 2 (Mad2) interaction to promote spindle assembly checkpoint (SAC) activity.
    Date DA; Burrows AC; Summers MK
    J Biol Chem; 2014 Apr; 289(16):11367-11373. PubMed ID: 24596092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aneuploid abortion correlates positively with MAD1 overexpression and miR-125b down-regulation.
    Zhao J; Li H; Chen G; Du L; Xu P; Zhang X; Xie M; Cao T; Li H
    Mol Cytogenet; 2021 Apr; 14(1):22. PubMed ID: 33902659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol.
    Kienitz A; Vogel C; Morales I; Müller R; Bastians H
    Oncogene; 2005 Jun; 24(26):4301-10. PubMed ID: 15782113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTA1 localizes to the mitotic spindle apparatus and interacts with TPR in spindle assembly checkpoint regulation.
    Liu J; Xue H; Li C; Chen X; Yao J; Xu D; Qian H
    Biochem Biophys Res Commun; 2023 Oct; 675():106-112. PubMed ID: 37467663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct interactions of mitotic arrest deficient 1 (MAD1) domains with each other and MAD2 conformers are required for mitotic checkpoint signaling.
    Ji W; Luo Y; Ahmad E; Liu ST
    J Biol Chem; 2018 Jan; 293(2):484-496. PubMed ID: 29162720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The MAD1 1673 G → A polymorphism alters the function of the mitotic spindle assembly checkpoint and is associated with a worse response to induction chemotherapy and sensitivity to treatment in patients with advanced epithelial ovarian cancer.
    Santibáñez M; Gallardo D; Morales F; López A; Prada D; Mendoza J; Castro C; de León DC; Oñate LF; Perez D; Mohar A; Herrera LA
    Pharmacogenet Genomics; 2013 Apr; 23(4):190-9. PubMed ID: 23407047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shugoshin is a Mad1/Cdc20-like interactor of Mad2.
    Orth M; Mayer B; Rehm K; Rothweiler U; Heidmann D; Holak TA; Stemmann O
    EMBO J; 2011 Jun; 30(14):2868-80. PubMed ID: 21666598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nucleoporin Nup153 affects spindle checkpoint activity due to an association with Mad1.
    Lussi YC; Shumaker DK; Shimi T; Fahrenkrog B
    Nucleus; 2010; 1(1):71-84. PubMed ID: 21327106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mad1/Mad2 complex as a template for Mad2 activation in the spindle assembly checkpoint.
    De Antoni A; Pearson CG; Cimini D; Canman JC; Sala V; Nezi L; Mapelli M; Sironi L; Faretta M; Salmon ED; Musacchio A
    Curr Biol; 2005 Feb; 15(3):214-25. PubMed ID: 15694304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons.
    Ryan SD; Britigan EM; Zasadil LM; Witte K; Audhya A; Roopra A; Weaver BA
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):E2205-14. PubMed ID: 22778409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer.
    Furlong F; Fitzpatrick P; O'Toole S; Phelan S; McGrogan B; Maguire A; O'Grady A; Gallagher M; Prencipe M; McGoldrick A; McGettigan P; Brennan D; Sheils O; Martin C; W Kay E; O'Leary J; McCann A
    J Pathol; 2012 Apr; 226(5):746-55. PubMed ID: 22069160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.